Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct-Dec;17(4):303-309.
doi: 10.1590/1677-5449.007117.

A pilot study comparing bovine mesenteric artery and expanded polytetrafluoroethylene grafts as non-autogenous hemodialysis options

Affiliations

A pilot study comparing bovine mesenteric artery and expanded polytetrafluoroethylene grafts as non-autogenous hemodialysis options

Bruno Morisson et al. J Vasc Bras. 2018 Oct-Dec.

Abstract

Background: Many dialysis patients do not have the necessary conditions for construction of a native arteriovenous fistula (AVF). Expanded Polytetrafluoroethylene (ePTFE) vascular prostheses are the most widely-used option, but it is known that they are inferior to native vein AVFs.

Objectives: To identify a graft with superior performance to ePTFE, comparing their results with those of AVFs made from bovine mesenteric arteries treated with L-Hydro technology (Labcor Laboratories ®).

Methods: A prospective and controlled study of 10 patients with AVFs constructed with ePTFE and 10 patients with L-Hydro bioprostheses, matched for comorbidities. The variables studied were: primary patency, assisted primary patency, and secondary patency, surgical manipulability, and prevalence of infections. The performance of prostheses was assessed by duplex-scan and repeated consultations with health professionals at hemodialysis clinics. The chi-square test was used for statistical analysis.

Results: After 1 year of postoperative follow-up, secondary and primary patency rates were higher for L-Hydro than ePTFE AVFs. Fewer interventions were needed to maintain AVF patency in the L-Hydro AVF group. The most common complication was graft thrombosis, which was more frequent in the ePTFE group. While the figures indicate more favorable outcomes in the L-Hydro AVFs, this could not be confirmed with the statistical treatment employed.

Conclusions: The L-Hydro graft appears to be a valuable alternative option for AVFs, since it seems to require fewer interventions to maintain patency when compared to ePTFE grafts.

Contexto: Muitos pacientes dialíticos apresentam condições desfavoráveis para confecção de fístula arteriovenosa (FAV) nativa. A prótese vascular de politetrafluoroetileno expandido (ePTFE) é a alternativa mais utilizada, porém, sabidamente inferior àquela com veias nativas.

Objetivos: Pesquisar um enxerto de performance superior à do ePTFE, confrontrando seus resultados com os de FAVs confeccionadas com artéria mesentérica bovina tratada com tecnologia L-Hydro (Labcor Laboratórios®).

Métodos: Estudo prospectivo e controlado, composto pelo grupo controle de 10 pacientes submetidos à confecção de FAV com ePTFE (FAV ePTFE) e grupo experimental de 10 pacientes com bioprótese L-Hydro (FAV L-Hydro). Os componentes foram pareados em relação às comorbidades apresentadas. As variáveis estudadas foram: perviedades primária, primária assistida e secundária, manuseabilidade e prevalência de infecções. A performance das próteses foi avaliada por duplex scan e por consultas seriadas realizadas por profissionais de clínicas de hemodiálise. O tratamento estatístico foi o teste do qui-quadrado.

Resultados: Após 1 ano de seguimento pós-operatório, as taxas de perviedade secundária e primária assistida foram maiores no grupo FAV L-Hydro do que no FAV ePTFE. As intervenções para manter a perviedade da FAV foram menores no grupo FAV L-Hydro. A complicação mais comum foi trombose do enxerto, mais frequente no grupo FAV ePTFE. Apesar de os números indicarem desfechos mais favoráveis nas FAV L-Hydro, não foi possível confirmar esse achado com o tratamento estatístico aplicado.

Conclusões: O enxerto L-Hydro parece ser uma alternativa valiosa para FAV, pois parece necessitar de menos intervenções para manutenção da perviedade, quando comparado ao enxerto de ePTFE.

Keywords: fistula; hemodialysis; patency.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: No conflicts of interest declared concerning the publication of this article.

Figures

Figure 1
Figure 1. Prosthesis before implantation.
Figure 2
Figure 2. Prosthesis in place.
Figure 3
Figure 3. Control duplex scan.
Figure 4
Figure 4. Complications.
Figura 1
Figura 1. Prótese antes do implante.
Figura 2
Figura 2. Prótese implantada.
Figura 3
Figura 3. Doppler de controle.
Figura 4
Figura 4. Complicações.

References

    1. Vascular Access Work Group Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48(Suppl 1):S248–73. doi: 10.1053/j.ajkd.2006.04.040. - DOI - PubMed
    1. Perera GB, Mueller MP, Kubaska SM, Wilson SE, Lawrence PF, Fujitani RM. Superiority of autogenous arteriovenous hemodialysis access: maintenance of function with fewer secondary interventions. Ann Vasc Surg. 2004;18(1):66–73. doi: 10.1007/s10016-003-0094-y. - DOI - PubMed
    1. Dallan LAO, Miyakawa AA, Lisboa LA, et al. Precocious structural and molecular (cDNA) changes in the human saphenous veins cultivated under arterial hemodynamic conditions. Rev Bras Cir Cardiovasc. 2004;19(2):126–135. doi: 10.1590/S1678-97412004000200006. - DOI
    1. Souza HJB. Substituição do tronco da artéria pulmonar em carneiros, utilizando heteroenxerto tubular valvado, preservado em l-hydro. São Paulo: Universidade Federal de São Paulo; 2011. tese.
    1. Souza HJB, Palma JHA, Casagrande ISJ, et al. Replacement of pulmonary artery trunk in sheep using tubular valved heterograft in non-aldehydic preservation. Rev Bras Cir Cardiovasc. 2012;27(3):419–428. doi: 10.5935/1678-9741.20120071. - DOI - PubMed

LinkOut - more resources